Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Dynamic Amyloid PET: Relationships to 18F-Flortaucipir Tau PET Measures

Fabio Raman, Yu-Hua Dean Fang, Sameera Grandhi, Charles F. Murchison, Richard E. Kennedy, John C. Morris, Parinaz Massoumzadeh, Tammie Benzinger, Erik D. Roberson and Jonathan McConathy
Journal of Nuclear Medicine February 2022, 63 (2) 287-293; DOI: https://doi.org/10.2967/jnumed.120.254490
Fabio Raman
1Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama;
2Alzheimer’s Disease Center, University of Alabama at Birmingham, Birmingham, Alabama;
3Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama;
4Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu-Hua Dean Fang
1Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sameera Grandhi
1Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama;
2Alzheimer’s Disease Center, University of Alabama at Birmingham, Birmingham, Alabama;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles F. Murchison
2Alzheimer’s Disease Center, University of Alabama at Birmingham, Birmingham, Alabama;
5Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard E. Kennedy
2Alzheimer’s Disease Center, University of Alabama at Birmingham, Birmingham, Alabama;
3Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John C. Morris
6Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, Missouri; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Parinaz Massoumzadeh
7Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tammie Benzinger
7Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik D. Roberson
2Alzheimer’s Disease Center, University of Alabama at Birmingham, Birmingham, Alabama;
3Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama;
4Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan McConathy
1Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama;
2Alzheimer’s Disease Center, University of Alabama at Birmingham, Birmingham, Alabama;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 63 no. 2 287-293
DOI 
https://doi.org/10.2967/jnumed.120.254490
PubMed 
34049986

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication August 27, 2020
  • Revision received April 23, 2021
  • Published online January 31, 2022.

Article Versions

  • previous version (May 28, 2021 - 07:34).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Fabio Raman1,2,3,4,
  2. Yu-Hua Dean Fang1,
  3. Sameera Grandhi1,2,
  4. Charles F. Murchison2,5,
  5. Richard E. Kennedy2,3,
  6. John C. Morris6,
  7. Parinaz Massoumzadeh7,
  8. Tammie Benzinger7,
  9. Erik D. Roberson2,3,4 and
  10. Jonathan McConathy1,2
  1. 1Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama;
  2. 2Alzheimer’s Disease Center, University of Alabama at Birmingham, Birmingham, Alabama;
  3. 3Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama;
  4. 4Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama;
  5. 5Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama;
  6. 6Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, Missouri; and
  7. 7Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri
  1. For correspondence or reprints, contact Jonathan McConathy (jmcconathy{at}uabmc.edu).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 7 Citations
  • 7 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • The complex pathway between amyloid β and cognition: implications for therapy
    William J Jagust, Charlotte E Teunissen, Charles DeCarli
    The Lancet Neurology 2023 22 9
  • International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer’s Disease
    Mei Tian, Chuantao Zuo, Ali Cahid Civelek, Ignasi Carrio, Yasuyoshi Watanabe, Keon Wook Kang, Koji Murakami, Valentina Garibotto, John O. Prior, Henryk Barthel, Yihui Guan, Jiaying Lu, Rui Zhou, Chentao Jin, Shuang Wu, Xiaohui Zhang, Yan Zhong, Hong Zhang
    Phenomics 2023 3 4
  • Multimodality imaging of neurodegenerative disorders with a focus on multiparametric magnetic resonance and molecular imaging
    James Ryan Loftus, Savita Puri, Steven P. Meyers
    Insights into Imaging 2023 14 1
  • Plasma Core Alzheimer’s Disease Biomarkers Predict Amyloid Deposition Burden by Positron Emission Tomography in Chinese Individuals with Cognitive Decline
    Ming Ni, Ze-Hua Zhu, Feng Gao, Lin-Bin Dai, Xin-Yi Lv, Qiong Wang, Xing-Xing Zhu, Ji-Kui Xie, Yong Shen, Shi-Cun Wang, Qiang Xie
    ACS Chemical Neuroscience 2023 14 1
  • Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier
    Dawn C. Matthews, Ana S. Lukic, Randolph D. Andrews, Miles N. Wernick, Stephen C. Strother, Mark E. Schmidt
    Alzheimer's & Dementia: Translational Research & Clinical Interventions 2022 8 1
  • Characterization of the glymphatic system and early-phase β-amyloid imaging in Alzheimer's disease: A simultaneous PET/MR study
    Yuying Jiao, Wei Han, Linhan Zhang, Mengjiao Wang, Zhehao Lyu, Yexin Su, Zeyu Wang, Lifan Wang, Jiafu Wang, Peng Xu, Yujie Hu, Yang Yang, Peng Fu
    Brain Research Bulletin 2025 226
  • Dual‐Phase C‐11 PiB PET Images for Detecting Tau Pathology in Cerebral Amyloid Angiopathy
    Meng‐Ting Chiang, Chia‐Ju Liu, Bo‐Ching Lee, Ruoh‐Fang Yen, Hsin‐Hsi Tsai
    Annals of Clinical and Translational Neurology 2025 12 5

Article usage

Article usage: May 2021 to May 2025

AbstractFullPdf
May 2021406013
Jun 20211255070
Jul 2021307021
Aug 2021191011
Sep 2021276012
Oct 202115307
Nov 202113909
Dec 2021158036
Jan 20221753337
Feb 2022357472106
Mar 202214434063
Apr 20228924057
May 20226321438
Jun 202215620333
Jul 2022423819
Aug 20223119720
Sep 20222026626
Oct 20221519516
Nov 20222211519
Dec 20229938614
Jan 20233438725
Feb 20231336124
Mar 20232237930
Apr 20231228123
May 20231821822
Jun 20231923724
Jul 20231626119
Aug 20231031626
Sep 20231027727
Oct 2023610312
Nov 20233510418
Dec 202375629
Jan 2024816416
Feb 20241414515
Mar 20241114341
Apr 2024205545
May 2024175535
Jun 2024316235
Jul 2024909733
Aug 20247210333
Sep 202433014
Oct 202483929
Nov 202472213
Dec 202414432
Jan 202572926
Feb 2025168830
Mar 202585533
Apr 202575035
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (2)
Journal of Nuclear Medicine
Vol. 63, Issue 2
February 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dynamic Amyloid PET: Relationships to 18F-Flortaucipir Tau PET Measures
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Dynamic Amyloid PET: Relationships to 18F-Flortaucipir Tau PET Measures
Fabio Raman, Yu-Hua Dean Fang, Sameera Grandhi, Charles F. Murchison, Richard E. Kennedy, John C. Morris, Parinaz Massoumzadeh, Tammie Benzinger, Erik D. Roberson, Jonathan McConathy
Journal of Nuclear Medicine Feb 2022, 63 (2) 287-293; DOI: 10.2967/jnumed.120.254490

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Dynamic Amyloid PET: Relationships to 18F-Flortaucipir Tau PET Measures
Fabio Raman, Yu-Hua Dean Fang, Sameera Grandhi, Charles F. Murchison, Richard E. Kennedy, John C. Morris, Parinaz Massoumzadeh, Tammie Benzinger, Erik D. Roberson, Jonathan McConathy
Journal of Nuclear Medicine Feb 2022, 63 (2) 287-293; DOI: 10.2967/jnumed.120.254490
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • 15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN
  • Google Scholar

More in this TOC Section

  • [18F]FDG PET/CT Predicts Patient Survival in Patients with Systemic Sclerosis–Associated Interstitial Lung Disease
  • Whole-Body [18F]DPA-714 Kinetic Assessment Using PET/CT Scanner with Long Axial Field of View
  • Clinical Outcomes of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience
Show more Clinical Investigation

Similar Articles

Keywords

  • 18F-florbetapir PET
  • 18F-flortaucipir PET
  • early-phase PET
  • early-frame amyloid PET
SNMMI

© 2025 SNMMI

Powered by HighWire